Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 199

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment

Open access
Dillon, Magnus T., Bergerhoff, Katharina F., Pedersen, Malin, Whittock, Harriet, Crespo-Rodriguez, Eva, Patin, Emmanuel C., Pearson, Alex, Smith, Henry G., Paget, James T.E., Patel, Radhika R., Foo, Shane, Bozhanova, Galabina, Ragulan, Chanthirika, Fontana, Elisa, Desai, Krisha, Wilkins, Anna C., Sadanandam, Anguraj, Melcher, Alan, McLaughlin, Martin, Harrington, Kevin J. · 2019 · Clinical Cancer Research

Abstract

Purpose: ATR inhibitors (ATRi) are in early phase clinical trials and have been shown to sensitize to chemotherapy and radiotherapy preclinically. Limited data have been published about the effect of these drugs on the tumor microenvironment. Experimental Design: We used an immunocompetent mouse model of HPV-driven malignancies to investigate the ATR inhibitor AZD6738 in combination with fractionated radiation (RT). Gene expression analysis and flow cytometry were performed posttherapy. Results: Significant radiosensitization to RT by ATRi was observed alongside a marked increase in immune cell infiltration. We identified increased numbers of CD3+ and NK cells, but most of this infiltrate was composed of myeloid cells. ATRi plus radiation produced a gene expression signature matching a type I/II IFN response, with upregulation of genes playing a role in nucleic acid sensing. Increased MHC I levels were observed on tumor cells, with transcript-level data indicating increased antigen processing and presentation within the tumor. Significant modulation of cytokine gene expression (particularly CCL2, CCL5, and CXCL10) was found in vivo, with in vitro data indicating CCL3, CCL5, and CXCL10 are produced from tumor cells after ATRi + RT. Conclusions: We show that DNA damage by ATRi and RT leads to an IFN response through activation of nucleic acid–sensing pathways. This triggers increased antigen presentation and innate immune cell infiltration. Further understanding of the effect of this combination on the immune response may allow modulation of these effects to maximize tumor control through antitumor immunity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-18-1821

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 199

Metadata

Authors
Dillon, M. T., Bergerhoff, K. F., Pedersen, M., Whittock, H., Crespo-Rodriguez, E., Patin, E. C., Pearson, A., Smith, H. G., Paget, J. T. E., Patel, R. R., Foo, S., Bozhanova, G., Ragulan, C., Fontana, E., Desai, K., Wilkins, A. C., Sadanandam, A., Melcher, A., McLaughlin, M., & Harrington, K. J.
Venue
Clinical Cancer Research
Published
2019-06-01
Volume
25
Issue
11
Pages
3392-3403
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2912622559
Cited by
199
References
11
FWCI
9.07
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-18-1821
The paper
Dillon, M. T., Bergerhoff, K. F., Pedersen, M., Whittock, H., Crespo-Rodriguez, E., Patin, E. C., Pearson, A., Smith, H. G., Paget, J. T. E., Patel, R. R., Foo, S., Bozhanova, G., Ragulan, C., Fontana, E., Desai, K., Wilkins, A. C., Sadanandam, A., Melcher, A., McLaughlin, M., & Harrington, K. J. (2019). ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-18-1821

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.